Company Search:
Advanced Search
Sponsored Links
Sinopharm Group Co Ltd Company Snapshot
Sinopharm Group Co Ltd operates within the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sinopharm Group Co Ltd with three other drug stores in Asia: Shanghai Pharmaceuticals Holding Co Ltd (2017 sales of 130.85 billion Chinese Renmimbi [US$20.83 billion] ), Alfresa Holdings Corporation of Japan (2.55 trillion Japanese Yen [US$23.86 billion] of which 88% was Wholesale Business of Pharmaceuticals fo), and Medipal Holdings Corporation which is also based in Japan (3.06 trillion Japanese Yen [US$28.65 billion] of which 68% was Pharmaceuticals And Food Precessing Whol).

Sales Analysis. During the year ended December of 2017, sales at Sinopharm Group Co Ltd were 277.72 billion Chinese Renmimbi (US$44.20 billion). This is an increase of 7.5% versus 2016, when the company's sales were 258.39 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Sinopharm Group Co Ltd (and since 2012, sales have increased a total of 105%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Sinopharm Group Co Ltd
  Stock Performance Chart for Sinopharm Group Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (4/13/2018): 27.47
(Figures in Chinese Renmimbi)
1 Week -21.3%   13 Weeks -6.8%  
4 Weeks -2.5%   52 Weeks -13.4%  
Sinopharm Group Co Ltd Key Data:
  Ticker: 1099 Country: China
  Exchanges: HKG Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2017 Sales 277,717,018,000
(Year Ending Jan 2018).
Employees: 55,241
  Currency: Chinese Renmimbi Market Cap: 76,015,560,964
  Fiscal Yr Ends: December Shares Outstanding: 2,767,095,089
  Share Type: H Gu Closely Held Shares: 1,574,785,200
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.